DNA Diagnostics Global Market Report 2024

Description

DNA diagnostics involves utilizing genetic testing techniques to examine DNA, RNA, and proteins for medical, forensic, or research purposes. These tests offer valuable insights into genetic predispositions, disease susceptibility, and ancestry, thereby revolutionizing the fields of medicine and genetics and providing effective tools for health management.

DNA diagnostic products encompass instruments, reagents, software, and services. Instruments are specialized equipment used for DNA sample analysis, employing technologies such as polymerase chain reaction, microarray, in-situ hybridization, sequencing, and mass spectrometry. These technologies find applications in diverse areas including oncology, infectious disease treatment, myogenic disorder treatment, clinical diagnostics, prenatal and pre-implantation testing. End users of DNA diagnostic products include point-of-care facilities, diagnostic centers, and individuals seeking self-testing or over-the-counter solutions.

The DNA diagnostics market research report is one of a series of new reports from The Business Research Company that provides DNA diagnostics market statistics, including DNA diagnostics industry global market size, regional shares, competitors with a DNA diagnostics market share, detailed DNA diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the DNA diagnostics industry. This DNA diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The DNA diagnostics market size has grown rapidly in recent years. It will grow from $20.90 billion in 2023 to $23.10 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The expansion observed in the historical period can be ascribed to heightened demand for personalized medicine, greater incorporation of genetic testing and molecular diagnostics into clinical settings, a surge in biomedical research activities, a rise in the number of cancer patients, and an increasing reliance on diagnostic tests.

The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $34.90 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The anticipated growth in the forecast period can be credited to several factors, including the rising incidence of cancers, escalating demand for standardized diagnostic tests, a growing prevalence of genetic disorders, heightened attention towards biomarker discovery, rare diseases, and orphan drugs, as well as the expansion of telemedicine and remote testing. Key trends expected in this period comprise the integration of microbiome analysis, utilization of blockchain technology, incorporation of multiple omics data, adoption of non-invasive testing methods, integration of multi-omics approaches, the advancement of portable and point-of-care DNA diagnostic devices, and the proliferation of next-generation sequencing (NGS) technologies.

The increasing incidence of genetic disorders is poised to drive the expansion of the DNA diagnostics market in the foreseeable future. Genetic disorders, characterized by health issues stemming from abnormalities in the genome, are on the rise due to several factors including enhanced diagnostic capabilities, broader genetic testing availability, environmental influences, and consanguinity within populations. These factors collectively contribute to a heightened awareness and identification of genetic disorders. DNA diagnostics plays a crucial role in precisely identifying genetic disorders through the analysis of genetic material, facilitating early diagnosis, tailored treatment approaches, and informed family planning decisions. For example, according to the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 neonatal deaths worldwide annually, with an additional 170,000 deaths occurring in children aged between 1 month and 5 years. Consequently, the escalating prevalence of genetic disorders serves as a key driver for the growth of the DNA diagnostics market.

Leading players in the DNA diagnostics sector are directing their efforts towards the development of innovative products, including liquid biopsy tests, designed to detect various types of cancer in their early stages. Liquid biopsy tests represent a minimally invasive diagnostic approach that identifies and analyzes biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, present in the bloodstream and originating from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a prominent US-based healthcare diagnostics company, introduced a novel liquid biopsy test named LabCorp Plasma Focus. This test is designed to identify targeted therapies for patients diagnosed with advanced or metastatic solid tumors. Leveraging genetic sequencing technology, LabCorp Plasma Focus evaluates circulating cell-free DNA (cfDNA) released by tumor cells, enabling oncologists to personalize treatment strategies and enhance patient care through targeted therapy plans.

In November 2022, Myriad Genetics Inc., a leading US-based company specializing in genetic testing and personalized medicine, acquired Gateway Genomics for approximately $67.5 million. This acquisition broadens Myriad's portfolio in women's health and oncology testing, offering patients more comprehensive and personalized genetic testing solutions. Gateway Genomics LLC, the acquired company, specializes in developing prenatal and pediatric genomic tests, aligning with Myriad's commitment to expanding its presence and capabilities in key segments of genetic diagnostics.

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

North America was the largest region in the DNA diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the DNA diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA diagnostics market consists of revenues earned by entities by providing services such as ancestry testing, paternity or maternity testing, genetic health risk assessment, carrier testing, pharmacogenetic testing, forensic DNA analysis, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA diagnostics market also includes sales of DNA extraction kits, thermal cyclers or polymerase chain reaction machines, DNA sequencers, gel electrophoresis systems, DNA microarrays, automated liquid handling systems, and DNA storage and preservation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on DNA diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for DNA diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The DNA diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry
3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications
4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)
Companies Mentioned: F. Hoffmann-La Roche Ltd; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r17922

1. Executive Summary

2. DNA Diagnostics Market Characteristics

3. DNA Diagnostics Market Trends And Strategies

4. DNA Diagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global DNA Diagnostics Market Size and Growth

5.1. Global DNA Diagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global DNA Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global DNA Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. DNA Diagnostics Market Segmentation

6.1. Global DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Reagents
Software And Services
6.2. Global DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Polymerase Chain Reaction
Microarray
In-situ Hybridization
Sequencing Technology
Mass Spectrometry
6.3. Global DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Infectious Diseases Treatment
Myogenic Disorder Treatment
Clinical Diagnostic Confirmation
Prenatal
Pre-Implantation
Other Applications
6.4. Global DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Point Of Care
Diagnostic Centers
Self-Testing Or Over-The-Counter (OTC)

7. DNA Diagnostics Market Regional And Country Analysis

7.1. Global DNA Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global DNA Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific DNA Diagnostics Market

8.1. Asia-Pacific DNA Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China DNA Diagnostics Market

9.1. China DNA Diagnostics Market Overview
9.2. China DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India DNA Diagnostics Market

10.1. India DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan DNA Diagnostics Market

11.1. Japan DNA Diagnostics Market Overview
11.2. Japan DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia DNA Diagnostics Market

12.1. Australia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia DNA Diagnostics Market

13.1. Indonesia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea DNA Diagnostics Market

14.1. South Korea DNA Diagnostics Market Overview
14.2. South Korea DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe DNA Diagnostics Market

15.1. Western Europe DNA Diagnostics Market Overview
15.2. Western Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK DNA Diagnostics Market

16.1. UK DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany DNA Diagnostics Market

17.1. Germany DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France DNA Diagnostics Market

18.1. France DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy DNA Diagnostics Market

19.1. Italy DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain DNA Diagnostics Market

20.1. Spain DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe DNA Diagnostics Market

21.1. Eastern Europe DNA Diagnostics Market Overview
21.2. Eastern Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia DNA Diagnostics Market

22.1. Russia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America DNA Diagnostics Market

23.1. North America DNA Diagnostics Market Overview
23.2. North America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA DNA Diagnostics Market

24.1. USA DNA Diagnostics Market Overview
24.2. USA DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada DNA Diagnostics Market

25.1. Canada DNA Diagnostics Market Overview
25.2. Canada DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America DNA Diagnostics Market

26.1. South America DNA Diagnostics Market Overview
26.2. South America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil DNA Diagnostics Market

27.1. Brazil DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East DNA Diagnostics Market

28.1. Middle East DNA Diagnostics Market Overview
28.2. Middle East DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa DNA Diagnostics Market

29.1. Africa DNA Diagnostics Market Overview
29.2. Africa DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. DNA Diagnostics Market Competitive Landscape And Company Profiles

30.1. DNA Diagnostics Market Competitive Landscape
30.2. DNA Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Danaher Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. DNA Diagnostics Market Other Major And Innovative Companies

31.1. Becton, Dickinson and Company
31.2. Laboratory Corporation
31.3. Quest Diagnostics Incorporated
31.4. Eurofins Scientific SE
31.5. Agilent Technologies
31.6. Illumina Inc
31.7. PerkinElmer Inc
31.8. bioMerieux SA
31.9. Beckman Coulter Inc
31.10. Sysmex Corporation
31.11. Bio-Rad Laboratories Inc
31.12. QIAGEN N.V.
31.13. Natera Inc
31.14. Myriad Genetics Inc.
31.15. BGI Genomics Co. Ltd.

32. Global DNA Diagnostics Market Competitive Benchmarking

33. Global DNA Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The DNA Diagnostics Market

35. DNA Diagnostics Market Future Outlook and Potential Analysis

35.1 DNA Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 DNA Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 DNA Diagnostics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer